J. Weclawek-Tompol

发表

The influence of genetic RFC1, MS and MTHFR polymorphisms on the risk of acute lymphoblastic leukemia relapse in children and the adverse effects of methotrexate.

A. Chybicka, Ewa Niedzielska, J. Węcławek-Tompol, 2013, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group

J. Wachowiak, M. Barańska, N. Irga-Jaworska, 2022, Frontiers in Oncology.

Melphalan, Etoposide, and Carboplatin Megatherapy with Autologous Stem Cell Transplantation in Children with Relapsing or Therapy-Resistant Extracranial Germ-Cell Tumors—A Retrospective Analysis

J. Trelińska, M. Ussowicz, A. Raciborska, 2020, Cancers.

Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials

U. Dirksen, A. Borkhardt, K. Bochennek, 2023, Cancers.

Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS)

S. Bielack, M. Münter, T. Klingebiel, 2019, Pediatric blood & cancer.

Solid Cancers in the Premature and the Newborn: Report of Three National Referral Centers.

C. Rodríguez-Galindo, J. Janowska, K. Bilska, 2016, Pediatrics and neonatology.

Unusual cause of skin nodules in a child – case report

J. Jagiello, B. Kazanowska, M. Ussowicz, 2019, Pediatria Polska.

Visceral leishmaniasis in a six-year-old patient – unexpected diagnosis: case study

B. Kazanowska, Katarzyna Sierżęga-Staykov, H. Pela, 2019, Pediatria Polska.

Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study

J. Wachowiak, B. Kazanowska, J. Kowalczyk, 2021, Annals of Hematology.

COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study

J. Wachowiak, W. Młynarski, N. Irga-Jaworska, 2021, Journal of Hematology & Oncology.

Correction to: COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study

J. Wachowiak, N. Irga-Jaworska, T. Szczepański, 2022, Journal of Hematology & Oncology.

COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study

J. Wachowiak, W. Młynarski, N. Irga-Jaworska, 2021, Journal of Hematology & Oncology.